XML 16 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Trading Arrangements of Section 16 Reporting Persons.

During the Company’s last fiscal quarter, the Company’s directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company’s securities set forth in the table below.

 

 

 

 

 

 

 

Types of Trading Arrangement

 

 

 

 

 

 

 

Name and Position

 

Action

 

Adoption Date

 

Rule
10b5-1*

 

Non-Rule 10b5-1**

 

Total Shares of Common Stock to be Sold

 

 

Total Shares of Common Stock to be Purchased

 

Expiration Date

Jennifer Lew, Chief Financial Officer

 

Adopt

 

4/10/2024

 

X

 

 

 

 

23,505

 

 

 

 

4/14/2025

Douglas Love, Chief Executive Officer

 

Adopt

 

4/12/2024

 

X

 

 

 

 

37,994

 

 

 

 

1/22/2025

Ted Yednock, Executive Vice President and Chief Innovation Officer

 

Adopt

 

4/12/2024

 

X

 

 

 

 

324,042

 

 

 

 

6/30/2025

__________________

* Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(a) of Regulation S-K under the Exchange Act.
Jennifer Lew [Member]  
Trading Arrangements, by Individual  
Name Jennifer Lew
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 4/10/2024
Expiration Date 4/14/2025
Arrangement Duration 370 days
Aggregate Available 23,505
Douglas Love [Member]  
Trading Arrangements, by Individual  
Name Douglas Love
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 4/12/2024
Expiration Date 1/22/2025
Arrangement Duration 286 days
Aggregate Available 37,994
Ted Yednock [Member]  
Trading Arrangements, by Individual  
Name Ted Yednock
Title Executive Vice President and Chief Innovation Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 4/12/2024
Expiration Date 6/30/2025
Arrangement Duration 436 days
Aggregate Available 324,042